Hykes Andrew's Form 4 filing
Inari Medical, Inc. (NARI) · filed May 18, 2023
- Accession no.
- 0001127602-23-016225
- Filed
- May 18, 2023
- Trade date
- May 16-17, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $2.57M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hykes AndrewCIK 0001806431 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2023 | Common Stock | SSaleDisposed | −818 | $70.87F2 | −$57,971.66 | 549,466 | Direct | |
| May 16, 2023 | Common Stock | SSaleDisposed | −16,945 | $70.87F3 | −$1,200,892.15 | 532,521 | Direct | |
| May 16, 2023 | Common Stock | SSaleDisposed | −153 | $70.87 | −$10,843.11 | 532,368 | Direct | |
| May 17, 2023 | Common Stock | SSaleDisposed | −16,079 | $69.19F4 | −$1,112,506.01 | 516,289 | Direct | |
| May 17, 2023 | Common Stock | SSaleDisposed | −2,630 | $69.19F5 | −$181,969.7 | 513,659 | Direct | |
| May 17, 2023 | Common Stock | SSaleDisposed | −51 | $69.19 | −$3,528.69 | 513,608 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $69.07 to $69.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $70.27 to $71.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $69.07 to $69.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $70.27 to $71.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.